Show simple item record

dc.contributor.authorKochhar, Rohiten
dc.contributor.authorAli, Hen
dc.contributor.authorMak, Soo Ken
dc.contributor.authorManoharan, Prakashen
dc.date.accessioned2010-08-07T10:51:01Z
dc.date.available2010-08-07T10:51:01Z
dc.date.issued2009-10
dc.identifier.citationMetastatic cutaneous malignant melanoma: spectrum of imaging findings and the role of multimodality imaging. 2009, 53 (5):467-78; quiz 478-9 J Med Imaging Radiat Oncolen
dc.identifier.issn1754-9485
dc.identifier.pmid19788482
dc.identifier.doi10.1111/j.1754-9485.2009.02076.x
dc.identifier.urihttp://hdl.handle.net/10541/109238
dc.description.abstractCutaneous malignant melanoma is one of the most lethal and widely metastasising cancers with unpredictable pathways of spread. One of the most significant factors associated with survival in patients who have distant metastases is the number of organ sites involved. Innovative treatment options are now available for metastatic melanoma, and diagnostic imaging has become crucial for accurate staging and restaging of disease. The objective of this pictorial review is to illustrate the imaging spectrum of metastatic cutaneous malignant melanoma including both the common and the relatively ubiquitous sites of involvement using both conventional cross-sectional and metabolic molecular imaging. This review also highlights the importance of combining multiple imaging methods for accurate staging of metastatic melanoma.
dc.language.isoenen
dc.subjectSkin Canceren
dc.subject.meshHumans
dc.subject.meshImage Enhancement
dc.subject.meshMelanoma
dc.subject.meshSkin Neoplasms
dc.subject.meshSubtraction Technique
dc.titleMetastatic cutaneous malignant melanoma: spectrum of imaging findings and the role of multimodality imaging.en
dc.typeArticleen
dc.contributor.departmentDepartment of Radiology, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, UK.en
dc.identifier.journalJournal of Medical Imaging and Radiation Oncologyen
html.description.abstractCutaneous malignant melanoma is one of the most lethal and widely metastasising cancers with unpredictable pathways of spread. One of the most significant factors associated with survival in patients who have distant metastases is the number of organ sites involved. Innovative treatment options are now available for metastatic melanoma, and diagnostic imaging has become crucial for accurate staging and restaging of disease. The objective of this pictorial review is to illustrate the imaging spectrum of metastatic cutaneous malignant melanoma including both the common and the relatively ubiquitous sites of involvement using both conventional cross-sectional and metabolic molecular imaging. This review also highlights the importance of combining multiple imaging methods for accurate staging of metastatic melanoma.


This item appears in the following Collection(s)

Show simple item record